Dominance of mutations in epigenetic regulators and a diversity of signaling alterations in blast‐phase BCR::ABL1‐negative myeloproliferative neoplasms

IF 10.1 1区医学 Q1 HEMATOLOGY

American Journal of Hematology Pub Date : 2024-10-19 DOI:10.1002/ajh.27503

Petruta Gurban, Cristina Mambet, Anca Botezatu, Laura G. Necula, Lilia Matei, Ana Iulia Neagu, Ioana Pitica, Marius Ataman, Aurelia Tatic, Alexandru Bardas, Mihnea A. Gaman, Camelia Dobrea, Mihaela Dragomir, Cecilia Ghimici, Silvana Angelescu, Doina Barbu, Oana Stanca, Marina Danila, Nicoleta Berbec, Andrei Colita, Ana Maria Vladareanu, Saviana Nedeianu, Mihaela Chivu‐Economescu, Coralia Bleotu, Daniel Coriu, Elise Sepulchre, Gabriela Anton, Carmen C. Diaconu, Stefan N. Constantinescu

引用次数: 0

查看原文本刊更多论文

胚泡期BCR::ABL1阴性骨髓增殖性肿瘤中表观遗传调控因子突变的优势和信号改变的多样性

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

American Journal of Hematology 医学-血液学

CiteScore

15.70

自引率

3.90%

发文量

363

审稿时长

3-6 weeks

期刊介绍： The American Journal of Hematology offers extensive coverage of experimental and clinical aspects of blood diseases in humans and animal models. The journal publishes original contributions in both non-malignant and malignant hematological diseases, encompassing clinical and basic studies in areas such as hemostasis, thrombosis, immunology, blood banking, and stem cell biology. Clinical translational reports highlighting innovative therapeutic approaches for the diagnosis and treatment of hematological diseases are actively encouraged.The American Journal of Hematology features regular original laboratory and clinical research articles, brief research reports, critical reviews, images in hematology, as well as letters and correspondence.